Emerging Technologies for Oral Peptide Delivery: From Bioinspired Systems to Smart Device-Assisted Drug Delivery
Pharmaceuticals · 23.08.2026 · 19 (9) · 1328
DOI: 10.3390/ph19091328 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 23.08.2026. Verfasst von Sara Vasović und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peptide therapeutics occupy a unique position between small organic compounds and large protein biomolecules, combining high specificity, strong pharmacological efficacy, and favourable safety profiles. Consequently, they have emerged as important therapeutic agents for a wide range of diseases, including metabolic and oncological disorders. However, oral administration of peptide drugs remains a major challenge due to extensive enzymatic degradation, low intestinal permeability, mucus entrapment, and presystemic metabolism within the gastrointestinal tract. This review provides a comprehensive overview of contemporary strategies for improving oral peptide delivery, with special emphasis on emerging pharmaceutical formulation technologies, bioinspired delivery systems and ingestible device-assisted approaches. A qualitative literature search was conducted using major scientific databases and included relevant publications available up to May 2026. The analysis identified the main barriers responsible for low oral bioavailability of peptide drugs, as well as promising approaches to overcoming these obstacles, including peptide modification, enzyme inhibition, permeation enhancement, mucolytic strategies, and advanced carrier systems. Special attention is given to multifunctional carrier systems, ingestible medical devices and bile acid-inspired technologies as emerging directions in oral peptide delivery. The convergence of pharmaceutical sciences, bioinspired formulation strategies and biomedical engineering is expected to accelerate the clinical translation of oral peptide formulations and enable their therapeutic potential to be fully exploited.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
- Institute for Pulmonary Diseases of Vojvodina, 21204 Sremska Kamenica, Serbia.
- Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
- Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Thailand.
- Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
ORCID-Profile: Nikola Martić, Somyot Chirasatitsin, Velibor Vasović, Nebojša Pavlović
Zitieren
APA
Vasović, S., Vasović, L., Martić, N., Chirasatitsin, S., Vasović, V., Vukmirović, S., & Pavlović, N. (2026). Emerging Technologies for Oral Peptide Delivery: From Bioinspired Systems to Smart Device-Assisted Drug Delivery. Pharmaceuticals, 19(9), 1328. https://doi.org/10.3390/ph19091328
Vancouver
Vasović S, Vasović L, Martić N, Chirasatitsin S, Vasović V, Vukmirović S, et al. Emerging Technologies for Oral Peptide Delivery: From Bioinspired Systems to Smart Device-Assisted Drug Delivery. Pharmaceuticals. 2026;19(9):1328. doi:10.3390/ph19091328
BibTeX
@article{Vasovi2026,
author = {Vasović, Sara and Vasović, Lucija and Martić, Nikola and Chirasatitsin, Somyot and Vasović, Velibor and Vukmirović, Saša and Pavlović, Nebojša},
title = {Emerging Technologies for Oral Peptide Delivery: From Bioinspired Systems to Smart Device-Assisted Drug Delivery},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {9},
pages = {1328},
doi = {10.3390/ph19091328}
}
EUVIMED